Calpin Gavin G, O'Neill Alice M, Davey Matthew G, Miller Peggy, Joyce William P
Department of Surgery, Galway Clinic, Doughiska, Co. Galway, Ireland.
Royal College of Surgeons in Ireland, 123St. Stephen's Green, Dublin 2, Ireland.
Surg Pract Sci. 2023 Jul 29;14:100204. doi: 10.1016/j.sipas.2023.100204. eCollection 2023 Sep.
The incidence of post-operative urinary retention (POUR) following inguinal hernia repair (IHR) is approximately 0.4% - 22.0%. POUR may lead to patient discomfort and catheter-related complications including urinary tract infection, urethral trauma, bladder overdistension and subsequent permanent bladder dysfunction. We aimed to perform a systematic review and meta-analysis of randomised control trials (RCT) evaluating the impact of administration of perioperative alpha-blockade to reduce the incidence of acute POUR following IHR.
A systematic review was performed as per PRISMA guidelines. The incidence of POUR in the alpha-blocker and control groups were expressed as dichotomous outcomes, reported as odds ratios (ORs) expressed with 95% confidence intervals (CIs) following estimation using the Mantel-Haenszel method.
Eight RCTs with a combined total of 918 patients were included. Of these, 53.7% (493/918) received alpha-blockers while 46.3% (425/918) did not. Five studies used tamsulosin, two used prazosin and one used phenoxybenzamine. Overall, the prescription of prophylactic alpha-blockers in the preoperative setting significantly reduced POUR compared to the control group (7.9% (39/493) vs 21.2% (90/425), OR: 0.31, 95% CI: 0.12-0.80, = 0.020).
Preoperative prescription of alpha-blockers reduced the incidence of POUR following inguinal hernia repair. The next generation of prospective randomised trials may identify which patients should be prescribed this medication prior to surgery.
腹股沟疝修补术(IHR)后术后尿潴留(POUR)的发生率约为0.4% - 22.0%。POUR可能导致患者不适以及与导尿管相关的并发症,包括尿路感染、尿道创伤、膀胱过度扩张及随后的永久性膀胱功能障碍。我们旨在对评估围手术期使用α-阻滞剂以降低IHR后急性POUR发生率的随机对照试验(RCT)进行系统评价和荟萃分析。
按照PRISMA指南进行系统评价。α-阻滞剂组和对照组中POUR的发生率以二分法结果表示,使用Mantel-Haenszel方法估计后报告为具有95%置信区间(CI)的比值比(OR)。
纳入了8项RCT,共计918例患者。其中,53.7%(493/918)接受了α-阻滞剂治疗,而46.3%(425/918)未接受。5项研究使用了坦索罗辛,2项使用了哌唑嗪,1项使用了酚苄明。总体而言,与对照组相比,术前预防性使用α-阻滞剂显著降低了POUR的发生率(7.9%(39/493)对21.2%(90/425),OR:0.31,95%CI:0.12 - 0.80,P = 0.020)。
术前使用α-阻滞剂可降低腹股沟疝修补术后POUR的发生率。下一代前瞻性随机试验可能会确定哪些患者在手术前应使用这种药物。